BioNTech (UK) Odds of Future Stock Price Finishing Under 101.27

0A3M Stock   116.10  4.01  3.58%   
BioNTech's future price is the expected price of BioNTech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BioNTech SE performance during a given time horizon utilizing its historical volatility. Check out BioNTech Backtesting, BioNTech Valuation, BioNTech Correlation, BioNTech Hype Analysis, BioNTech Volatility, BioNTech History as well as BioNTech Performance.
  
Please specify BioNTech's target price for which you would like BioNTech odds to be computed.

BioNTech Target Price Odds to finish below 101.27

The tendency of BioNTech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to  101.27  or more in 90 days
 116.10 90 days 101.27 
about 24.43
Based on a normal probability distribution, the odds of BioNTech to drop to  101.27  or more in 90 days from now is about 24.43 (This BioNTech SE probability density function shows the probability of BioNTech Stock to fall within a particular range of prices over 90 days) . Probability of BioNTech SE price to stay between  101.27  and its current price of 116.1 at the end of the 90-day period is about 49.11 .
Assuming the 90 days trading horizon BioNTech has a beta of 0.0552. This suggests as returns on the market go up, BioNTech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BioNTech SE will be expected to be much smaller as well. Additionally BioNTech SE has an alpha of 0.4303, implying that it can generate a 0.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioNTech Price Density   
       Price  

Predictive Modules for BioNTech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioNTech SE. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
111.93115.73119.53
Details
Intrinsic
Valuation
LowRealHigh
107.39111.19127.71
Details

BioNTech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioNTech is not an exception. The market had few large corrections towards the BioNTech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioNTech SE, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioNTech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.43
β
Beta against Dow Jones0.06
σ
Overall volatility
11.22
Ir
Information ratio 0.08

BioNTech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioNTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioNTech SE can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BioNTech SE appears to be risky and price may revert if volatility continues
About 62.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: BioNTech ADR Earns Relative Strength Rating Upgrade - Investors Business Daily

BioNTech Technical Analysis

BioNTech's future price can be derived by breaking down and analyzing its technical indicators over time. BioNTech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioNTech SE. In general, you should focus on analyzing BioNTech Stock price patterns and their correlations with different microeconomic environments and drivers.

BioNTech Predictive Forecast Models

BioNTech's time-series forecasting models is one of many BioNTech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioNTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BioNTech SE

Checking the ongoing alerts about BioNTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioNTech SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioNTech SE appears to be risky and price may revert if volatility continues
About 62.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: BioNTech ADR Earns Relative Strength Rating Upgrade - Investors Business Daily

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.